Skip to main content
OpenTrials

Clinical trial condition

Ciliopathies

Explore clinical trials studying Ciliopathies. Study availability and eligibility vary by location and protocol.

296 public trials 74 recruiting studies
Refine in advanced search Browse all conditions

Ciliopathies trial results

Completed

8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

NCT01451827

Conditions
Abnormalities, Multiple, Autosomal Dominant Polycystic Kidney Disease, Ciliopathies, +12 more
Locations
  • Otsuka Investigational Site Huntsville, Alabama, United States
  • Otsuka Investigational Site Mobile, Alabama, United States
  • Otsuka Investigational Site Peoria, Arizona, United States
  • Otsuka Investigational Site Tempe, Arizona, United States
View all 35 locations
View Trial Details
Completed

Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease

NCT02160145

Conditions
Abnormalities, Multiple, Autosomal Dominant Polycystic Kidney Disease, Chronic Disease, +19 more
Locations
  • Birmingham, Alabama, United States
  • Huntsville, Alabama, United States
  • Mobile, Alabama, United States
  • Phoenix, Arizona, United States
View all 230 locations
View Trial Details
Completed

Dose-finding Study of New Tolvaptan Formulation in Subjects With ADPKD

NCT01210560

Conditions
Abnormalities, Multiple, Autosomal Dominant Polycystic Kidney Disease, Ciliopathies, +12 more
Locations
  • Tufts-New England Medical Center Boston, Massachusetts, United States
  • Davita Clinical Research Minneapolis, Minnesota, United States
  • Mayo Medical Center Rochester, Minnesota, United States
  • University Hospitals of Cleveland/Case Cleveland, Ohio, United States
View Trial Details

Related conditions